Grisold Wolfgang, Grisold Anna, Marosi Christine, Meng Stefan, Briani Chiara
Department of Neurology, Kaiser Franz Josef Hospital, Kundratstraße 3, Vienna 1100, Austria (W.G.); Department of Neurology, Medical University of Vienna, Waehringer Gürtel 18-20, Vienna 1090, Austria (A.G.); Department of Oncology, Medical University of Vienna, Waehringer Gürtel 18-20, Vienna 1090, Austria (C.M.); Department of Radiology, Kaiser Franz Josef Hospital, Kundratstraße 3, Vienna 1100, Austria (S.M.); Department of Neurosciences, University of Padova, Via Giustiniani, 5, Padova 35128, Italy (C.B.).
Neurooncol Pract. 2015 Dec;2(4):167-178. doi: 10.1093/nop/npv025. Epub 2015 Aug 1.
Neuropathy occurs with various manifestations as a consequence of lymphoma, and an understanding of the etiology is necessary for proper treatment. Advances in medical imaging have improved the detection of peripheral nerve involvement in lymphoma, yet tissue diagnosis is often equally important. The neoplastic involvement of the peripheral nervous system (PNS) in lymphoma can occur within the cerebrospinal fluid (CSF), inside the dura, or outside of the CSF space, affecting nerve root plexuses and peripheral nerves. The infiltration of either cranial or peripheral nerves in lymphoma is termed neurolymphomatosis (NL). These infiltrations can occur as mononeuropathy, multifocal neuropathy, symmetric neuropathies, or plexopathies. In rare cases, intravascular lymphoma (IL) can affect the PNS and an even rarer condition is the combination of NL and IL. Immune-mediated and paraneoplastic neuropathies are important considerations when treating patients with lymphoma. Demyelinating neuropathies, such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy, occur more frequently in non-Hodgkin's lymphoma than in Hodgkin's disease. Paraproteinemic neuropathies can be associated with lymphoma and paraneoplastic neuropathies are rare. While the treatment of lymphomas has improved, a knowledge of neurotoxic, radiotherapy, neoplastic, immune-mediated and paraneoplastic effects are important for patient care.
神经病变是淋巴瘤的一种后果,有多种表现形式,了解其病因对于恰当治疗至关重要。医学成像技术的进步提高了淋巴瘤累及周围神经的检测率,但组织诊断往往同样重要。淋巴瘤累及周围神经系统(PNS)可发生于脑脊液(CSF)内、硬脑膜内或CSF间隙外,影响神经根丛和周围神经。淋巴瘤累及颅神经或周围神经被称为神经淋巴瘤病(NL)。这些浸润可表现为单神经病、多灶性神经病、对称性神经病或神经丛病。在罕见情况下,血管内淋巴瘤(IL)可累及PNS,更罕见的情况是NL与IL并存。在治疗淋巴瘤患者时,免疫介导的和副肿瘤性神经病变是重要的考虑因素。脱髓鞘性神经病变,如格林-巴利综合征和慢性炎症性脱髓鞘性多发性神经根神经病,在非霍奇金淋巴瘤中比在霍奇金病中更常见。副蛋白血症性神经病变可与淋巴瘤相关,而副肿瘤性神经病变则很罕见。虽然淋巴瘤的治疗已有改善,但了解神经毒性、放疗、肿瘤、免疫介导和副肿瘤效应对于患者护理很重要。